We’ve gotten word that the FDA has approved the exciting Dexcom SHARE system, the first mobile device approval of its kind that allows data from a continuous glucose monitor to be beamed via Bluetooth wireless technology to as many as five smartphones anywhere!
In a prospective cohort study, researchers looked at data on 14,437 women who participated in the Nurses’ Health Study II. Data was collected from the years of 1989-2001. Participants were aged 24 to 44 years and had no chronic diseases.
Every adult with Type 1 knows, at least basically, how to count carbs and estimate the amount of insulin needed to cover those carbs. Fewer know how to seek out the foods that may help in maintaining good blood glucose levels. We’ve done some research to compile some food news for people with Type 1 […]
Managing diabetes requires day-to-day care, but it doesn’t have to be complicated. Learning the basics, getting advice and support from health professionals like your physician, certified diabetes educator and registered dietitian, and doing a little planning can help you live well with diabetes.
On November 3, the FDA will host an unprecedented discussion between the diabetes community and its senior agency leadership (both drugs and devices). The event will be live webcasted from 1 – 4 pm, and will include a panel of people with type 1 and type 2 diabetes, as well as representatives from ADA, JDRF, […]
Recently, news swept the world that Harvard scientist Dr. Douglas Melton and his team have developed a lab technique that can transform not-fully-developed human stem cells into billions of new insulin-producing beta cells. What does this mean? Is this a cure? What are the next steps? How do I get my new beta cells? How […]
Stevia, an FDA-approved sweetener, attempts to be the answer. It’s becoming increasingly popular, blending in between the pink, blue and yellow packets at coffee shops, even making its way into brand name soda products.
The Vigilant folks have pretty smooth marketing materials that state: “Bee helps patients by creating a log book of insulin injection and blood sugar level data which they may share with their loved ones and healthcare providers.” And that’s true, to an extent.
Spanish researchers analyzed data from the PREDIMED randomized controlled trial, which included men and women aged 55-80 years old at high risk of heart disease. Participants were randomly assigned to one of three diets: a Mediterranean diet supplemented with extra-virgin olive oil, a Mediterranean diet supplemented with nuts or a low-fat diet as the control.
This month Glooko announced the launch of MeterSync Blue, a small device that allows users to upload glucose meter data to Android and iPhone apps via Bluetooth. MeterSync Blue is compatible with over 30 meters, including many made by Abbott, Bayer, LifeScan, and Roche – see the list here.
At the recent Health 2.0 conference, Medtronic demoed its in-development Guardian Mobile system, which will send real-time CGM readings straight from a transmitter to a smartphone app via Bluetooth. Medtronic believes the product will only require a sensor, a Bluetooth enabled transmitter, and a smart phone – no receiver required.
Researchers compared the effects on health-related quality of life (HRQoL) of a 2-year intervention with a low-fat diet (LFD) or a low-carbohydrate diet (LCD) based on four group-meetings to achieve compliance.
“The grapefruit juice lowered blood glucose to the same degree as metformin,” said Joseph Napoli, professor and chair of nutritional sciences and toxicology at the University of California, Berkeley. “That means a natural fruit drink lowered glucose levels as effectively as a prescription drug.”
Also known as dulaglutide, Trulicity is a glucagon-like peptide-1 (GLP-1) receptor agonist, which helps normalize blood sugar levels by encouraging the release of insulin, which helps the body better use available blood glucose, while suppressing the stimulation of glucose production.
Different types of insulin are used to manage type 1 diabetes with insulin injections. Long-acting insulin takes about one hour to begin lowering blood sugar levels and lasts up to 26 hours, while intermediate-acting insulin takes one to three hours to begin lowering blood sugar levels and lasts up to 16 hours.
Eggs don’t have a bad effect on cholesterol levels in people with type 2 diabetes, a new study suggests. Researchers also found that eating an egg-rich diet for 3 months was linked to better appetite control, and may also provide a greater sense of feeling full.
The hunt for a cure for type 1 diabetes has recently taken a “tremendous step forward”, scientists have said. A team at Harvard University used stem cells to produce hundreds of millions of the cells in the laboratory. Tests on mice showed the cells could treat the disease, which experts described as “potentially a major […]
Last month, we reported on the Diabetes Technology Society’s progress on a post-market surveillance program to keep tabs on the accuracy of glucose meters already on the market. We’re happy to bring you an overview report on the joint AACE/ACA conference straight from Bennet, who was of course there representing our D-Community and taking part […]
Cases of tuberculosis are set accelerate worldwide unless action is taken to curb diabetes, a chronic condition that weakens the immune system and triples the risk a person will develop the lung disease, health experts warned on Wednesday.
In what may be a step toward a cure for type 1 diabetes, researchers say they’ve developed a large-scale method for turning human embryonic stem cells into fully functioning beta cells capable of producing insulin.